Skip to main content
KoBioLabs, Inc. logo

KoBioLabs, Inc. — Investor Relations & Filings

Ticker · 348150 ISIN · KR7348150004 KO Manufacturing
Filings indexed 174 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 348150

About KoBioLabs, Inc.

http://kobiolabs.com/en/

KoBioLabs, Inc. is a biotechnology company that develops innovative microbiome-based therapeutics. The company utilizes its proprietary Smartiome® platform, an integrated system for discovering novel drug candidates that employs AI-driven multi-omics analysis and a comprehensive microbiome library with a reverse-translation approach. KoBioLabs is focused on creating a pipeline of new drugs to treat a range of immune, metabolic, and brain disorders. The company also applies advanced technologies, including a microbe-based drug delivery system (mDDS) and biofoundry techniques, to enhance the efficacy of its treatments and address unmet medical needs.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is titled “분기보고서 (제 13 기) 2026년 01월 01일~2026년 03월 31일” and contains detailed quarterly financial statements, management discussion of business activities, sales figures for the first quarter, revenue breakdowns, risk management, and other substantive financial data. This is a comprehensive interim/quarterly report rather than an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-05-14 Korean
[기재정정]정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled “정기주주총회결과” (Results of the Annual General Meeting) and details the approval of financial statements, dividend resolutions, board appointments, and vote tallies for each agenda item at the 12th AGM held 2026-03-26. This is exactly a declaration of shareholder voting results at a general meeting, matching the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2026-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 92% confidence The document is a formal notification filed with the Financial Services Commission/Korea Exchange regarding the appointment and dismissal (resignation) of outside directors at 주식회사 고바이오랩. It details changes in the board of directors (사외이사 선임·해임·중도퇴임), including names, dates, and reasons. This matches the ‘Board/Management Information’ category (Code: MANG).
2026-03-27 Korean
주식매수선택권부여에관한신고
Regulatory Filings Classification · 80% confidence The document is a formal filing to the Financial Services Commission/KRX detailing the grant of stock purchase options (“주식매수선택권 부여”) by the company to its directors and employees. It is not an earnings release, annual or interim report, nor a proxy or voting document. It also does not announce an immediate share issuance or buyback; rather it provides the full details of an employee stock option grant under Korean securities regulation. There is no dedicated category in the taxonomy for option grants, so it falls into the generic “Regulatory Filings” fallback category (RNS).
2026-03-26 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed voting outcomes for each agenda item, including financial statement approval, director appointments, stock options, etc. This clearly represents the official results of shareholder votes at a general meeting, matching the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-03-26 Korean
대표이사변경
Board/Management Information Classification · 90% confidence The document is a regulatory announcement detailing changes in the company’s chief executive officer (former CEO 고광표 replaced by 이한승), including board resolution date, attendance, and biographical details. This fits the definition of a Board/Management Information filing (announcement of changes in senior management).
2026-03-26 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.